Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00056134 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: Dendritic cell vaccine plus denileukin difitox

Sponsor

University Hospital Erlangen